Evidence map›Paper›PMID 31997114›Full record

ArticleDocumenta ophthalmologica. Advances in ophthalmology2020

ERG shrinks by 10% when reducing dark adaptation time to 10 min, but only for weak flashes.

Michael Bach, Cornelia Meroni, Sven P Heinrich

Abstract readComparative Study
In one paragraph

Article in Documenta ophthalmologica. Advances in ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael BachEye Center, Medical Center, University of Freiburg, Killianstr. 5, 79106, Freiburg, Germany. michael.bach@uni-freiburg.de.ORCID 0000-0003-2028-535X
Cornelia MeroniEye Center, Medical Center, University of Freiburg, Killianstr. 5, 79106, Freiburg, Germany.
Sven P HeinrichEye Center, Medical Center, University of Freiburg, Killianstr. 5, 79106, Freiburg, Germany.ORCID 0000-0003-4906-3937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare dark-adapted (DA) ERG between 10, 15 and 20 min of dark adaptation (DA).

methodsIn a counterbalanced random block design, 40 healthy adult subjects were dark-adapted for 10, 15 or 20 min before we recorded ERGs to nine flash strengths from 0.001 to 10.0 cd s/m

resultsThe a-wave amplitude was not affected by any adaptation condition. For the b-wave amplitude, effects of reduced DA time are stronger for weaker flashes: Reducing DA from 20 to 10 min had no measurable effect on the DA 3 ERG, but reduced the DA 0.01 b-wave significantly (p < 0.0001) to 87 ± 2% (mean ± SEM). The DA 0.001 b-wave (not part of the ISCEV ERG Standard) was more affected (down to 72 ± 4%). There was a small, but significant, increase, only for weak flashes, in a- and b-wave peak times for 20 compared to 10-min dark adaptation time.

conclusionReducing dark adaptation time from 20 to 10 min in normal participants has no effect on the ISCEV DA 3 and DA 10 ERG. The reduction in DA 0.01 ERGs to 87 ± 2% agrees with Hamilton and Graham (Doc Ophthalmol 133:11-19, 2016. https://doi.org/10.1007/s10633-016-9554-x ) who found 90 ± 2% and with Asakawa et al. (Doc Ophthalmol 139:33-44, 2019. https://doi.org/10.1007/s10633-019-09693-8 ) who found 83%. Pending verification in pathophysiological states, the current results suggest that one might be able to correct for the 10% amplitude loss when gaining 10 min through shortened DA.

Indexed as

Photic StimulationAdultDark AdaptationElectroretinographyFemaleHealthy VolunteersHumansMaleRetinal Rod Photoreceptor CellsTime FactorsYoung AdultDark adaptationDark-adapted ERGISCEV ERG StandardTime

Identifiers

PMID31997114
PMCPMC7347516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.